Compounds > 1,2,3,4-tetrahydroquinoline
Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Disease Models, Animal

1,2,3,4-tetrahydroquinoline has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Cao, Z; Fu, W; Ma, X; Sun, N; Wang, Y; Xu, J; Zhou, K; Zhu, C1
Baptista, EF; Barbosa, RAQ; Barenco, TS; Campos de Carvalho, AC; Couto, MT; Domingos, AE; Ferraz, AP; Nascimento, JHM; Ponte, CG; Resende, GO; Seara, FAC; Sottani, TBB; Souza, NSC; Takiya, CM1
Bařinka, C; Benoy, V; Kozikowski, AP; Kutil, Z; Langley, B; Pavlíček, J; Picci, C; Robers, MB; Shen, S; Tavares, MT; Ustinova, K; Van Den Bosch, L; Zhang, G; Zimprich, CA1
Furuya, K; Kawai, K; Miyakawa, M; Nagata, N; Nishiyama, D; Oguro, N; Ohyabu, Y; Satsukawa, M; Yamamoto, N1

Other Studies

4 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Disease Models, Animal

ArticleYear
Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.
    European journal of medicinal chemistry, 2020, Feb-01, Volume: 187

    Topics: Animals; Cell Differentiation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Female; Fluorescence Resonance Energy Transfer; Imiquimod; Mice; Mice, Inbred BALB C; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Nuclear Receptor Subfamily 1, Group F, Member 3; Psoriasis; Quinolines; Structure-Activity Relationship; Sulfonamides; Th17 Cells

2020
BK
    Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:4

    Topics: Animals; Calcium Channel Agonists; Disease Models, Animal; Large-Conductance Calcium-Activated Potassium Channels; Pulmonary Arterial Hypertension; Quinolines; Rats; Rats, Wistar; Treatment Outcome; Vascular Remodeling; Vascular Resistance; Vasoconstriction; Vasodilation; Ventricular Function, Right

2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
    Journal of medicinal chemistry, 2021, 04-22, Volume: 64, Issue:8

    Topics: Acetylation; Animals; Benzamides; Binding Sites; Charcot-Marie-Tooth Disease; Crystallography, X-Ray; Disease Models, Animal; Half-Life; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Phenotype; Protein Isoforms; Quinolines; Structure-Activity Relationship; Tubulin

2021
Lead evaluation of tetrahydroquinolines as nonsteroidal selective androgen receptor modulators for the treatment of osteoporosis.
    ChemMedChem, 2014, Volume: 9, Issue:1

    Topics: Animals; Binding Sites; Caco-2 Cells; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Female; Half-Life; Humans; Hydrogen Bonding; Molecular Docking Simulation; Niacinamide; Osteoporosis; Protein Structure, Tertiary; Quinolines; Rats; Receptors, Androgen; Testosterone Congeners; Thermodynamics

2014